Bon Secours Mercy Health and Lirio, LLC announced Wednesday their new strategic partnership at the 38th annual J.P. Morgan Healthcare Conference, initiated by a direct investment from Bon Secours Mercy Health in Lirio’s innovative behavior change AI platform. John Starcher, president and CEO of Bon Secours Mercy Health will join Lirio’s board of directors. Lirio and Bon Secours Mercy Health will co-develop new behavior change programs that influence health decision-making for those at risk for chronic diseases, such as diabetes and hypertension. These programs will eventually be marketed and sold to other health systems globally under commercial terms agreed to between both parties.
Read the full article: Bon Secours Mercy Health and Lirio Announce Partnership and Investment //